The briefing
Nature reports on an oral, glucose-responsive probiotic that transiently colonizes the gut and secretes therapeutic factors when glucose exceeds a threshold, enabling on-demand dosing. In diabetic mouse and non-human primate models, long-term use improved glycaemic control and lipid profiles while reducing signs of complications.
Original headline
Glucose-responsive probiotics for glycaemic modulation in mice and monkeys